This article has been updated with additional information from Thermo Fisher Scientific's Q3 earnings call.

NEW YORK (GenomeWeb) – Thermo Fisher Scientific reported a 9 percent increase in third quarter revenues today before the opening of the stock market, driven by growth in all four of its business segments, in particular life sciences solutions and analytical instruments.

"We had another great quarter, and we're right where we should be at this point of the year," said President and CEO Marc Casper during a conference call to discuss the firm's earnings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.